BCRF funds 260+ outstanding investigators who are all working tirelessly to advance breast cancer research. This #WomensHistoryMonth, BCRF is highlighting some of our female investigators who have made notable contributions to the field. Today, we focus on disparities in breast cancer. Their research is uncovering the factors that drive unequal outcomes and access to care and paving the way for more equitable prevention, diagnosis, and treatment. Want to dive deeper? Read about even more trailblazing female researchers driving breakthroughs in breast cancer here: https://lnkd.in/eVZfGw29
The Breast Cancer Research Foundation
学术研究
The highest-rated breast cancer org in the U.S. We fund research to find a cure in our lifetime.
关于我们
BCRF is the highest-rated breast cancer organization in the U.S. We provide critical funding for cancer research worldwide to fuel advances in tumor biology, genetics, prevention, treatment, metastasis and survivorship. Since our founding in 1993 by Evelyn H. Lauder, BCRF has raised more than half a billion dollars for lifesaving research. Through a unique and streamlined grants program, we seek out the brightest minds in science and medicine and give them the necessary resources to pursue their best ideas. As a result, researchers are able to make discoveries and design new approaches to address all aspects of breast cancer—and do so in record time. Learn more and join us at www.bcrf.org.
- 网站
-
https://www.bcrf.org
The Breast Cancer Research Foundation的外部链接
- 所属行业
- 学术研究
- 规模
- 51-200 人
- 总部
- New York
- 类型
- 非营利机构
- 创立
- 1993
- 领域
- research、breast cancer、health、nonprofit和prevention
地点
-
主要
28 W 44th St
US,New York,10036
The Breast Cancer Research Foundation员工
-
Kathleen Tripp
-
Laura Lang
Narragansett Ventures
-
Marisa Rubio, PhD
Advancing Scientific Discovery for a Cure | Leading Innovative Cancer Research Initiatives | Research Program Management
-
Jodi Patkin
Chief Marketing & Communications Officer, Breast Cancer Research Foundation | Award-Winning Executive | Mission-Driven Leader | Brand Lover | Team…
动态
-
This #InternationalWomensDay, we honor BCRF founder Evelyn H. Lauder, a visionary who changed the future of breast cancer research and whose legacy continues to inspire and save lives worldwide. ?? The Estée Lauder Companies Inc.
-
"With my immediate family having been impacted twice, I want to do my part to raise money for research. I am running for all women and families that can benefit from research."—Annie Scenna Annie is running the 2025 #UnitedNYCHalf with #TeamBCRF in honor of her mom and aunt who are both breast cancer survivors. "This disease has greatly affected my family and I am incredibly grateful they are both in remission," she said. Help us thank Annie in the comments, and if you want to support her fundraising, you can do so here: https://bit.ly/41pPUNt
-
-
BCRF funds 260+ outstanding investigators who are all working tirelessly to bring much-needed breast cancer breakthroughs to patients. This #WomensHistoryMonth, BCRF is highlighting some of our female investigators who have made notable contributions to the field. Today, we focus on the field of genetics. Their research is deepening our understanding of inherited risk and gene mutations, paving the way for more precise prevention, diagnosis, and treatment. Want to dive deeper? Read about even more trailblazing female researchers driving breakthroughs in breast cancer here: https://lnkd.in/eVZfGw29
-
"Research is important to me as it helps expand our understanding and empowers us to make informed decisions driving progress and innovation for a successful future. As someone who works in healthcare, it's crucial to diagnose, treat, and care for patients by providing evidence-based solutions to improve patient outcomes."—Ryan Fiddler Ryan is running the 2025 #UnitedNYCHalf with #TeamBCRF to show support to the people around him who have been diagnosed with breast cancer. "The goal is to raise awareness and get people involved, support work that improves treatments, and ultimately find a cure for breast cancer," he said. Help us thank Ryan in the comments, and if you want to support his fundraising, you can do so here: https://bit.ly/4kqL7UM
-
-
When Tamisha was diagnosed with triple-negative breast cancer (TNBC) in 2019 she was faced with one of the most aggressive forms of breast cancer and an uncertain future. Her biggest fear was not being there for all of life’s special moments with her three children. But thanks to research, she received successful treatment and is thriving today. This #TripleNegativeBreastCancerDay, Tamisha is sharing three essential things everyone should know about TNBC. And right now at BCRF.org/donate, your gift is 3X MATCHED—meaning TRIPLE the impact for lifesaving breast cancer research.
-
Triple-negative breast cancer (TNBC) is an aggressive form of breast cancer that has fewer targeted therapies than other forms. But thanks to groundbreaking research, there are more treatment options—and more hope—than ever before. Learn more about this subtype and how research is improving outcomes: https://bit.ly/43gZV24
-
"When I was diagnosed at 26, my whole world was turned upside down. But thanks to research, I’m here—about to run a half marathon and proving what is possible. Supporting BCRF means investing in that next breakthrough that could spare someone else from going through what I went through and giving hope to others impacted by this disease."—Emma Downey Emma is done with active treatment and is running the 2025 #UnitedNYCHalf with #TeamBCRF to make a difference for others impacted by the disease. "Crossing the finish line with BCRF will be for everyone who has and still is fighting this battle, for those who supported me and stood by me through the darkest days, and for the researchers working tirelessly to create a future where no other woman, young or old, has to face this diagnosis," she said. Help us thank Emma in the comments, and if you want to support her fundraising, you can do so here: https://bit.ly/4brIAG0
-
-
By 2050, breast cancer is projected to reach staggering levels, with an estimated 3.2 million new cases and 1.1 million lives lost each year, according to a just-released United Nations report. This alarming forecast highlights the urgent need for more research to improve prevention, early detection, and treatment—work that BCRF is advancing every day. But this burden is not shared equally. Structural barriers, resources, and disparities in healthcare access mean that marginalized communities face higher mortality rates and worse outcomes. At BCRF, we are committed to funding the most advanced, equity-driven, global research to close these gaps and improve outcomes for all impacted by the disease.
-
-
At the San Antonio Breast Cancer Symposium in December, leading researchers—including BCRF-supported scientists—unveiled groundbreaking advancements in treatments. From targeted therapies to better understanding triple-negative breast cancer, these findings bring us closer to saving lives and improving outcomes for patients everywhere. ?? Learn more about how research is transforming breast cancer care: https://bit.ly/3QBXhg0